Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of EsoBiotec is 0.8% (low). The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Financials
No processed annual-account figures available.
To financials
People & board
14 mandates
6
active directors
Angela ThompsonDirectorCarsten LinnemannDirectorFONDS CAPITAL A RISQUE 2020Director+11 in history
All directors & mandates Publicationslatest 27-10-2025
68
publications in the State Gazette2 directors appointed, 5 resigningAll publications & acts Network & structure
8
connected companiesSee network & structure
Connections
8 connected companiesParent · 419 subsidiaries · 7 locations
Control→
via Héléna Pozios · Permanent representative
former→
Trust signals
3 signalsMore than 3 years active
Founded in 2020 — past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone0.8%
Low
0%0,5%1,5%4%10%≥25%
Young company
+Lower-failure-rate sector
−Lower-risk legal form
−
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Company registry (CBE)
Crossroads BankActivities
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72109Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72190
Primary activity highlighted.
Names & trade names
| Legal nameFR | EsoBiotec |
Registered office
Rue André Dumont 5
1435 Mont-Saint-Guibert, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.